Galectin Therapeutics reported $3.7M in Trade Creditors for its fiscal quarter ending in June of 2024.





Trade Creditors Change Date
AbbVie USD 33.3B 29.71B Jun/2026
Bristol-Myers Squibb USD 4.63B 470M Sep/2026
Galectin Therapeutics USD 3.7M 99K Jun/2024
Gilead Sciences USD 934M 260M Sep/2026
Immunic USD 10.12M 2.54M Sep/2026
Incyte USD 235.37M 1.16B Sep/2026
Merck USD 5.03B 1.2B Sep/2026